Vol 9, No 4 (August 2018): Journal of Gastrointestinal Oncology

Original Article

Outcomes of patients in the national cancer database treated non-surgically for localized rectal cancer
Emma B. Holliday, Pamela K. Allen, Hesham Elhalawani, Omar Abdel-Rahman
Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United States
Waqar Haque, Vivek Verma, E. Brian Butler, Bin S. Teh
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition
David A. Fabrizio, Thomas J. George Jr, Richard F. Dunne, Garrett Frampton, James Sun, Kyle Gowen, Mark Kennedy, Joel Greenbowe, Alexa B. Schrock, Aram F. Hezel, Jeffrey S. Ross, Phillip J. Stephens, Siraj M. Ali, Vincent A. Miller, Marwan Fakih, Samuel J. Klempner
Impact of intensity modulated radiation therapy on survival in anal cancer
Jaymin Jhaveri, Lael Rayfield, Yuan Liu, Mudit Chowdhary, Sibo Tian, Richard J. Cassidy, Theresa Gillespie, Pretesh R. Patel, Jerome C. Landry, Kirtesh R. Patel
The value of oxaliplatin in the systemic treatment of locally advanced rectal cancer
Teresa Martín-Aragón, Javier Serrano, Juana Benedí, Rosa M. Meiriño, Pilar García-Alonso, Felipe A. Calvo
Neoadjuvant PET and MRI-based intensity modulated radiotherapy leads to less toxicity and improved pathologic response rates in locally advanced rectal cancer
John M. David, Gillian Gresham, Salma K. Jabbour, Matthew Deek, Shant Thomassian, John M. Robertson, Neil B. Newman, Joseph M. Herman, Arsen Osipov, Peyman Kabolizadeh, Richard Tuli
A case-control study of the association between metabolic syndrome and colorectal cancer: a comparison of International Diabetes Federation, National Cholesterol Education Program Adults Treatment Panel III, and World Health Organization definitions
Vaidehi Ulaganathan, Mirnalini Kandiah, Zalilah Mohd Shariff
Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis
Whitney Guerrero, Gitonga Munene, Paxton V. Dickson, Zachary E. Stiles, Johnathan Mays, Andrew M. Davidoff, Evan S. Glazer, David Shibata, Jeremiah L. Deneve
The incidence of colorectal cancer in patients with previously removed polyp(s)—a cross-sectional study
Ruud J. L. F. Loffeld, Boris Liberov, Pascale E. P. Dekkers
Chemotherapy re-challenge response rate in metastatic colorectal cancer
Alexandra E. Chambers, Jacob Frick, Natalee Tanner, Richard Gerkin, Madappa Kundranda, Tomislav Dragovich
Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer
Michael Chuong, Shahed N. Badiyan, Man Yam, Zuofeng Li, Katja Langen, William Regine, Christopher Morris, James Snider III, Minesh Mehta, Soon Huh, Michael Rutenberg, Romaine C. Nichols
Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma
Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Mauro Daniel Spina Donadio, Audrey Cabral, Thiago Pimentel Muniz, Luciana de Moura Leite, Lucas Ferreira Sant’Ana
Role of lymph node ratio in selection of adjuvant treatment (chemotherapy vs. chemoradiation) in patients with resected gastric cancer
Brice Jabo, Matthew J. Selleck, John W. Morgan, Sharon S. Lum, Khaled Bahjri, Mayada Aljehani, Carlos A. Garberoglio, Mark E. Reeves, Jukes P. Namm, Naveenraj L. Solomon, Fabrizio Luca, Gary Yang, Maheswari Senthil
Clinicopathologic features and outcomes of gastrointestinal stromal tumors arising from the esophagus and gastroesophageal junction
Andrew M. Briggler, Rondell P. Graham, Gustavo F. Westin, Andrew L. Folpe, Dawn E. Jaroszewski, Scott H. Okuno, Thorvardur R. Halfdanarson
Overexpression of SSH1 in gastric adenocarcinoma and its correlation with clinicopathological features
Seyedeh Saideh Daryabari, Reza Safaralizadeh, Mohammadali Hosseinpourfeizi, Yaghoub Moaddab, Behrooz Shokouhi
Stereotactic body radiation therapy following transarterial chemoembolization for unresectable hepatocellular carcinoma
Michael Buckstein, Edward Kim, Aaron Fischman, Seth Blacksburg, Marcelo Facciuto, Myron Schwartz, Kenneth Rosenzweig
Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
Kei Moriya, Tadashi Namisaki, Shinya Sato, Akitoshi Douhara, Masanori Furukawa, Hideto Kawaratani, Kosuke Kaji, Mitsuteru Kitade, Naotaka Shimozato, Yasuhiko Sawada, Kenichiro Seki, Soichiro Saikawa, Hiroaki Takaya, Takemi Akahane, Akira Mitoro, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji
Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?
Veeravich Jaruvongvanich, Tomoki Sempokuya, Linda Wong
Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas
Muhammad M. Fareed, Lyudmila DeMora, Nestor F. Esnaola, Crystal S. Denlinger, Andreas Karachristos, Eric E. Ross, John Hoffman, Joshua E. Meyer

Review Article

The gut microbiome and colorectal cancer: a review of bacterial pathogenesis
Jessica D. Dahmus, Drew L. Kotler, David M. Kastenberg, C. Andrew Kistler